Cancer is the world's second leading cause of death. Cancer patients experience clinically significant emotional distress symptoms such as depression and anxiety, which reduce their quality of life (QoL) and resilience and interfere with treatment adherence. Resilience is a valuable characteristic that contributes to a person's mental and physical well-being. Evidence suggests that motivation is related to resilience. The desire to recover from physical or psychological traumatic events improves a person's ability to deal with life's challenges. Thus, resilience protects against and helps to reduce the negative effects of psychosocial health issues such as depression, anxiety, fear, and helplessness. QoL has become an important health-related outcome measure for communities and healthcare systems in recent years. This outcome measure is based on a multidimensional concept that includes: subjective perceptions of positive and negative aspects of cancer symptoms, physical, emotional, social, and cognitive functions, disease symptoms, and treatment side effects.
Conventionally, the endpoints of medical care for cancer patients are focused on survival rate, local control rate, or complication rate. These assessments do not capture the patients’ mental and emotional wellbeing, although the diagnosis of cancer considerably affects a patient’s emotional and psychosocial status. It is imperative to address this important area in this population and there should be a multidisciplinary survivorship clinic within health care centers comprising of a neurologist, an oncologist, a neuropsychologist, and a psychologist, as well as other medical, surgical, neurological, psychological, and educational specialties with experience in cancer survivors. Long‐term monitoring and follow‐up support are essential due to the emergence of late effects which can impact the patients' psychological wellbeing and QoL. In clinical studies targeted at improving survival, it is critical to incorporate QoL and toxicity-related end goals. The social endpoints must be made a priority for a clinical trial which may help in future therapeutic advancements.
This Research Topic will cover, but is not limited to, the following themes:
1. Neurocognitive outcomes and intervention in cancer patients
2. Psychological outcomes and intervention in cancer patients
3. Long-term psychological impact of cancer on work/employment of the survivors
Types of Manuscript: Original Research article (Observational studies, Randomized Control trial, Quasi-experimental studies, validation studies ), Protocols (only RCTs), Systematic reviews , Meta analysis
Cancer is the world's second leading cause of death. Cancer patients experience clinically significant emotional distress symptoms such as depression and anxiety, which reduce their quality of life (QoL) and resilience and interfere with treatment adherence. Resilience is a valuable characteristic that contributes to a person's mental and physical well-being. Evidence suggests that motivation is related to resilience. The desire to recover from physical or psychological traumatic events improves a person's ability to deal with life's challenges. Thus, resilience protects against and helps to reduce the negative effects of psychosocial health issues such as depression, anxiety, fear, and helplessness. QoL has become an important health-related outcome measure for communities and healthcare systems in recent years. This outcome measure is based on a multidimensional concept that includes: subjective perceptions of positive and negative aspects of cancer symptoms, physical, emotional, social, and cognitive functions, disease symptoms, and treatment side effects.
Conventionally, the endpoints of medical care for cancer patients are focused on survival rate, local control rate, or complication rate. These assessments do not capture the patients’ mental and emotional wellbeing, although the diagnosis of cancer considerably affects a patient’s emotional and psychosocial status. It is imperative to address this important area in this population and there should be a multidisciplinary survivorship clinic within health care centers comprising of a neurologist, an oncologist, a neuropsychologist, and a psychologist, as well as other medical, surgical, neurological, psychological, and educational specialties with experience in cancer survivors. Long‐term monitoring and follow‐up support are essential due to the emergence of late effects which can impact the patients' psychological wellbeing and QoL. In clinical studies targeted at improving survival, it is critical to incorporate QoL and toxicity-related end goals. The social endpoints must be made a priority for a clinical trial which may help in future therapeutic advancements.
This Research Topic will cover, but is not limited to, the following themes:
1. Neurocognitive outcomes and intervention in cancer patients
2. Psychological outcomes and intervention in cancer patients
3. Long-term psychological impact of cancer on work/employment of the survivors
Types of Manuscript: Original Research article (Observational studies, Randomized Control trial, Quasi-experimental studies, validation studies ), Protocols (only RCTs), Systematic reviews , Meta analysis